EPROSARTAN MESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eprosartan Mesylate, and what generic alternatives are available?
Eprosartan Mesylate is a drug marketed by Norvium Bioscience and is included in one NDA.
The generic ingredient in EPROSARTAN MESYLATE is eprosartan mesylate. There are eleven drug master file entries for this compound. Additional details are available on the eprosartan mesylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EPROSARTAN MESYLATE?
- What are the global sales for EPROSARTAN MESYLATE?
- What is Average Wholesale Price for EPROSARTAN MESYLATE?
Summary for EPROSARTAN MESYLATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 1 |
Patent Applications: | 1,404 |
DailyMed Link: | EPROSARTAN MESYLATE at DailyMed |
Recent Clinical Trials for EPROSARTAN MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Quintiles, Inc. | Phase 3 |
Abbott | Phase 3 |
author! et al. BV | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for EPROSARTAN MESYLATE
Paragraph IV (Patent) Challenges for EPROSARTAN MESYLATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TEVETEN | Tablets | eprosartan mesylate | 400 mg and 600 mg | 020738 | 1 | 2010-05-10 |
US Patents and Regulatory Information for EPROSARTAN MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Norvium Bioscience | EPROSARTAN MESYLATE | eprosartan mesylate | TABLET;ORAL | 202012-001 | Nov 16, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Norvium Bioscience | EPROSARTAN MESYLATE | eprosartan mesylate | TABLET;ORAL | 202012-002 | Nov 16, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |